Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000462842 | SCV000546359 | likely benign | Charcot-Marie-Tooth disease type 4 | 2024-12-16 | criteria provided, single submitter | clinical testing | |
ARUP Laboratories, |
RCV000507530 | SCV000605102 | uncertain significance | not specified | 2016-09-28 | criteria provided, single submitter | clinical testing | |
Molecular Genetics Laboratory, |
RCV001173158 | SCV001336236 | uncertain significance | Charcot-Marie-Tooth disease | criteria provided, single submitter | clinical testing | ||
Ambry Genetics | RCV002393104 | SCV002700817 | uncertain significance | Inborn genetic diseases | 2021-06-17 | criteria provided, single submitter | clinical testing | The p.T495A variant (also known as c.1483A>G), located in coding exon 11 of the SH3TC2 gene, results from an A to G substitution at nucleotide position 1483. The threonine at codon 495 is replaced by alanine, an amino acid with similar properties. This amino acid position is conserved. In addition, this alteration is predicted to be tolerated by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. |
Prevention |
RCV004533178 | SCV004743060 | likely benign | SH3TC2-related disorder | 2021-02-17 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |